ESC Congress 2011

27 - 31 August 2011, Paris - France

Session Details

Poster session 4: Heart failure - Left ventricular dysfunction
Mon 29 Aug 14:00 - 18:00 Heart failure, other Poster Session Posters - Poster Zone C

Abstract Slides/e-posters Video Report

List of Presentations

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
14:00P3504(W)Gender- and age-related mortality and treatment among hospitalized acute heart failure patients: data from epi-cardio registry.To Be Announced
14:00P3505Adaptive servo ventilation improves cardiac function and long term prognosis in heart failure patients with Cheyne-Stokes respiration Akiomi YOSHIHISA (Fukushima, JP)
14:00P3506Cardiac resynchronization therapy after cardiac surgeryPatrycja PRUSZKOWSKA-SKRZEP (Zabrze, PL)
14:00P3507The echocardiographic changes of right ventricle during short and mid-term follow-up after cardiac resynchronization therapy Rudolf PRAUS (Hradec Kralove, CZ)
14:00P3508Are there any echocardiographic differences between patients with recent dilated cardiomyopathy with and without inflammation detected by the endomyocardial biopsy?Lenka SPINAROVA (Brno, CZ)
14:00P3509Metaloproteinase -9 correlates independently with obstructive pulmonary disease in chronic heart failure patientsKaterina VITLIANOVA (Sofia, BG)
14:00P3510Heterozygous LmnadelK32/+ mutant mice develop progressive dilated cardiomyopathy and alterations of the ubiquitin-proteasome systemMarie-Elodie CATTIN (Paris, FR)
14:00P3511Levels of tumor necrosis factor-alpha and interleukin-6 in patients with acute heart failureViktoriia ZOLOTAIKINA (Kharkov, UA)
14:00P3512Leptin and adiposity in systolic heart failure: association with cardiac structural changesNadine CLAUSELL (Porto Alegre, BR)
14:00P3513Existence of masked obstructive sleep apnea after adaptive servo-ventilation therapy in heart failure patient with central sleep apneaNoriaki TAKAMA (Maebashi, JP)
14:00P3514Impact of cardiac resynchronization therapy on physical ability and quality of life in patients with chronic heart failureWiktoria WOJCIECHOWSKA (Krakow, PL)
14:00P3515VO2 max to measure the functional status of obese heart failure patients.Joffrey POZZO (Toulouse, FR)
14:00P3516Minimally invasive coronary sinus lead reposition technique for the treatment of phrenic nerve stimulationLaszlo GELLER (Budapest, HU)
14:00P3517Evaluation of domain-specific cognitive defects in patients with chronic heart failureMasataka WATANABE (Melbourne, AU)
14:00P3518Deterioration of renal function and 2-year mortality in patients with acute heart failure and preserved or reduced ejection fraction Nikolaos PATSOURAKOS (Piraeus, GR)
14:00P3519Levosimendan out of critical care units, efficacy, safety and perfusion protocolsMaria LAZARO SALVADOR (Toledo, ES)
14:00P3520Cardiac markers and hemodynamics after intrahepatic portosystemic shunt in liver cirrhosisRadek PUDIL (Hradec Kralove, CZ)
14:00P3521Are homocysteine and allantoin levels of prognostic value in chronic heart failure ?Pauline FOURNIER (Toulouse, FR)
14:00P3522Markers of malnutrition in hospitalized patients with heart failureJuan Luis BONILLA PALOMAS (Cordoba, ES)
14:00P3523Prevalence of heart failure in Beta thalassaemia major patientsAtooshe ROHANI (Mashad, IR)
14:00P3524Acute kidney injury and outcomes in acute decompensated heart failure in KoreaMi-Seung SHIN (Incheon, KR)
14:00P3525The change of nutritional status influences the duration of hospital stay on patients with systolic heart failureShigeto NAMIUCHI (Sendai, JP)
14:00P3526N-GAL indicating acute kidney injury and GFR influence the prognosis of patients with acute symptomatic pulmonary embolism Maciej KOSTRUBIEC (Warsaw, PL)
14:00P3527OptiVol alert is associated with higher BNP value in patients with cardiac dysfunction: MOMOTARO study (monitoring and management of OptiVol alert to reduce heart failure admission)Nobuhiro NISHII (Okayama, JP)
14:00P3528N-terminal proBNP as a good predictor for successful weaning from intra-aortic balloon pumping in acute heart failureYukichi TOKITA (Tokyo, JP)
14:00P3529Cardiac effects of late exercise training in rats with different sizes of myocardial infarctionDaniele MENDES GUIZONI (Campinas, BR)
14:00P3530A potential cross-talk between fat and bone in patients with chronic heart failureGoran LONCAR (Belgrade, RS)
14:00P3531Experimental myocardial infarction versus doxorubicin-induced cardiotoxicity as interventions to build up ovine models of chronic heart failure: comparative characteristics.Andrea DE LORENZI (La Plata, AR)
14:00P3532Influence of T786C polymorphism of the endothelial nitric oxide synthase gene on insulin resistance in patients with ischemic and non ischemic heart failure Cecilia VECOLI (Pisa, IT)
14:00P3533Components of life quality evaluation in heart failure clinicFatima Das Dores CRUZ (Sao Paulo, BR)
14:00P3534Clinical characteristics of heart failure in Chile. Chilean registry of heart failure: ICARO 2002- 2010Luis SEPULVEDA MORALES (Santiago, CL)
14:00P3535Myocardial recovery during LVAD support is associated with both increase in peak oxygen uptake and reduced dependent on pump speed during cardiopulmonary exercise testingMumin Abdur Razzak NOOR (Uxbridge, GB)
14:00P3536Myocardial myostatin and follistatin protein expression in spontaneously hypertensive rats with heart failureRicardo DAMATTO (Botucatu, BR)
14:00P3537Impact of flow-mediated vasodilation on exercise tolerance and long-term survival in chronic heart failure patientsLeonid VORONKOV (Kyiv, UA)
14:00P3538Lipolytic effects of B-type natriuretic peptide1-32 in adipose tissue of heart failure patients compared to healthy controls Vojtech MELENOVSKY (Prague 4, CZ)
14:00P3539Low triiodothyronine syndrome is a prognostic marker of 5 year survival in heart failureMaria NIKOLAOU (Athens, GR)
14:00P3540Prognostic value of lower limbs arterial resistance in chronic heart failureLeonid VORONKOV (Kyiv, UA)
14:00P3541Knee flexors muscle strength is the predictor of long-term survival in chronic heart failureYevgen BESAGA (Kyiv, UA)
14:00P354212 - week Nordic Walking training improves physical fitness and quality of life in patients with systolic heart failureAndrzej LEJCZAK (Wroclaw, PL)
14:00P3543Two hour plasma glucose is associated with noninvasively assessed left ventricular filling pressure, 6-minute walking distance and NT-proBNP in chronic systolic heart failureMichael EGSTRUP (Copenhagen, DK)
14:00P3544The effects of long-term niacin threapy on the course of heart failure due to volume overloadVera TORRES (Prague 4, CZ)
14:00P3545Mitogen-activated protein kinases and nuclear factor-kappaB participation in skeletal muscle response to oxidative stress in rats with heart failurePaula Felippe MARTINEZ (Campo Grande, BR)
14:00P3546Autophagic myocardial degeneration and improvement of ventricular function in obesity cardiomyopathy as an appropriate model of load-induced heart failureTsunenori SAITO (Tokyo, JP)
14:00P3547Rate of LV pressure rise is an important confounder when assessing left ventricular electrical dyssynchrony by onset of myocardial shorteningKristoffer RUSSELL (Oslo, NO)
14:00P3548Dependency of cardiac resynchronization therapy on myocardial viability at the left ventricular lead positionMichael BECKER (Aachen, DE)
14:00P3549Disease-related risk factors for subclinical left ventricular dysfunction in patients with psoriatic arthritisQing SHANG (Hong Kong, HK)
14:00P3550Left ventricular geometry of normotensive progeny of patients with hypertensionAmam Chinyere MBAKWEM (Lagos, NG)
14:00P3551Radiation effects on LV function in breast cancer patients: comparison of conventional, tissue-Doppler and tracking-based assessmentJens-Uwe VOIGT (Leuven, BE)
14:00P3552Quantitative assessment of right atrial functions by strain and strain rate imaging in patients with heart failureNasim NADERI (Tehran, IR)
14:00P3553Inhibition of neovascularisation by bevacizumab has a direct effect on left ventricular function, a prospective study.Archontoula MICHELONGONA (Pireaus, GR)
14:00P3554Progression of impaired left ventricular contractility in patients with isolated diastolic dysfunction and heart failure with preserved ejection fractionLiang ZHONG (Singapore, SG)
14:00P3555Cytoskeletal remodeling of desmin is a accurate measure of cardiac dysfunction. Agnieszka PAWLAK (Legionowo, PL)
14:00P3556Arterial-ventricular interaction in patients with heart failure with normal ejection fraction (HFNEF) and systolic heart failure (SYSHF)Ashan GUNARATHNE (Cannock, GB)
14:00P3557Selective heart rate reduction by ivabradine improves aortic distensibility as well as left ventricular systolic and diastolic function in diabetes type 2 (db-) mice Jan-Christian REIL (Homburg, DE)
14:00P3558Reversal of secondary pulmonary hypertension with continuous flow LVAD: successful bridge to orthotopic cardiac transplantGayathri KUMARASINGHE (New South Wales, AU)
14:00P3559Relationship between proximal aortic stiffness assessed with CMR and left ventricular diastolic function in asymptomatic subjects with preserved left ventricular ejection fraction Alban REDHEUIL (Paris, FR)